JOHNSON & JOHNSON
S-8 POS, 1999-11-19
PHARMACEUTICAL PREPARATIONS
Previous: FRONTIER OIL CORP /NEW/, 8-K, 1999-11-19
Next: JOHNSON & JOHNSON, S-3, 1999-11-19




   As filed with the Securities and Exchange Commission on November 19, 1999
                                                  Registration No. 333-86611
==============================================================================

                                 UNITED STATES
                      SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D.C. 20549
                           ------------------------
                        POST-EFFECTIVE AMENDMENT NO. 2
                            ON FORM S-8 TO FORM S-4
                            REGISTRATION STATEMENT
                                     Under
                          THE SECURITIES ACT OF 1933
                           ------------------------

                               Johnson & Johnson
            (Exact name of Registrant as specified in its charter)

              New Jersey                                   22-1024240
    (State of other jurisdiction                        (I.R.S. Employer
   of incorporation or organization)                   Identification No.)

                          One Johnson & Johnson Plaza
                        New Brunswick, New Jersey 08933
         (Address, including ZIP code, of Principal Executive Offices)
                           ------------------------
        Centocor, Inc. Consultant Non-Qualified Stock Option Agreements
                Centocor, Inc. 1983 Incentive Stock Option Plan
              Centocor, Inc. 1987 Non-Qualified Stock Option Plan
  Centocor, Inc. 1989 Non-Employee Directors' Non-Qualified Stock Option Plan
                           (Full Title of the Plans)
                           ------------------------
                             Joseph S. Orban, Esq.
                               Johnson & Johnson
                          One Johnson & Johnson Plaza
                        New Brunswick, New Jersey 08933
                           Telephone: (732) 524-0400
                    (Name, address, and telephone number,
                  including area code, of agent for service)
                           ------------------------
                                  Copies to:
                            Robert A. Kindler, Esq.
                         Robert I. Townsend, III, Esq.
                            Cravath, Swaine & Moore
                                Worldwide Plaza
                               825 Eighth Avenue
                              New York, NY 10019
                                (212) 474-1000

                        CALCULATION OF REGISTRATION FEE

==============================================================================
                                           Proposed   Proposed
                                            maximum    maximum
      Title of                 Amount      offering   aggregate   Amount of
    securities to               to be       price     offering   registration
    be registered            registered    per share    price        Fee
==============================================================================
Common Stock, par value
  $1.00 per share........  15,273 shares(1)   (2)        (2)         (2)
==============================================================================

(1)  These shares were originally registered on the Registration Statement on
     Form S-4 to which this Amendment relates.
(2)  Not applicable. All filing fees payable in connection with the
     registration of these securities were paid in connection with the filing
     of the Preliminary Proxy Statement on Schedule 14A of Centocor, Inc. on
     August 20, 1999 and the filing of the Registration Statement on Form S-4
     on September 7, 1999, to register 61,011,098 shares of Johnson & Johnson
     common stock, par value $1.00 per share, issuable to shareholders of
     Centocor, Inc., including the 15,273 additional shares being registered
     hereunder which may be issued pursuant to the Plans referred to above.
     See "Explanatory Statement".
==============================================================================


<PAGE>


                             EXPLANATORY STATEMENT

     This Post-Effective Amendment relates to an additional 15,273 shares of
common stock, par value $1.00 per share ("J&J Common Stock"), of Johnson &
Johnson ("J&J") issuable upon the exercise of stock options granted under the
Centocor, Inc. Consultant Non-Qualified Stock Option Agreements, the Centocor,
Inc. 1983 Incentive Stock Option Plan, the Centocor, Inc. 1987 Non-Qualified
Plan and the Centocor, Inc. 1989 Non-Employee Directors' Non-Qualified Stock
Option Plan (collectively, the "Plans"). This Post-Effective Amendment is
intended to supplement, and does not supersede, the Post-Effective Amendment
No. 1 on Form S-8 (the "Post-Effective Amendment") to the Registration
Statement on Form S-4 (the "Form S-4") (Registration No. 333-86611), which
relates to 3,443,516 shares of J&J Common Stock issuable upon the exercise of
stock options granted under the Plans.

     As a result of the October 6, 1999 merger (the "Merger") of Admiral
Merger Corp., a Pennsylvania corporation and a wholly owned subsidiary of
Johnson & Johnson, with and into Centocor, Inc., a Pennsylvania corporation
("Centocor"), each option outstanding immediately prior to the effective time
of the Merger, including the options to which the 15,273 shares of J&J Common
Stock being registered hereunder relate, was converted into an option to
acquire, on the same terms and conditions as were applicable under such option
immediately prior to the effective time of the Merger, the number of shares of
J&J Common Stock (rounded down to the nearest whole share) equal to the
product of (x) the number of shares of common stock, par value $.01 per share,
of Centocor for which such option was theretofore exercisable and (y) 0.639.
The exercise price for each option shall be equal to the exercise price per
share for such option immediately prior to the effective time of the Merger
divided by 0.639 (rounded up to the nearest whole cent).

     The designation of this Post-Effective Amendment as Post-Effective
Amendment No. 2 on Form S-8 (Registration No. 333-86611) denotes that this
Post-Effective Amendment relates only to shares of J&J Common Stock issuable
upon the exercise of stock options under the Plans and that this is the second
Post-Effective Amendment to the Form S-4 filed with respect to such shares.




<PAGE>


                                                                             2

                                    PART II

              INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 3. Incorporation of Documents by Reference.

     The following documents filed by J&J with the Securities and Exchange
Commission (the "SEC") are incorporated herein by reference:

     (a)  J&J's Annual Report on Form 10-K for the fiscal year ended January
          3, 1999, as amended by an Amendment thereto filed on Form 10-K/A on
          June 22, 1999.

     (b)  J&J's Quarterly Report on Form 10-Q for the quarter ended April 4,
          1999.

     (c)  J&J's Quarterly Report on Form 10-Q for the quarter ended July 4,
          1999.

     (d)  J&J's Quarterly Report on Form 10-Q for the quarter ended October 3,
          1999.

     (e)  The description of J&J Common Stock set forth in J&J's Registration
          Statements filed pursuant to Section 12 of the Securities Exchange
          Act of 1934 (the "Exchange Act"), including any amendments or
          reports filed for the purpose of updating such description.

     All documents filed by J&J pursuant to Sections 13(a), 13(c), 14 or 15(d)
of the Exchange Act after the date hereof and prior to the filing of a
post-effective amendment which indicates that all securities offered hereby
have been sold or which deregisters all securities then remaining unsold,
shall be deemed to be incorporated by reference herein and to be a part hereof
from the date of filing of such documents (such documents, and the documents
enumerated above, being hereinafter referred to as "Incorporated Documents");
provided, however, that the documents enumerated above or subsequently filed
by J&J pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act in
each year during which the offering made hereby is in effect prior to the
filing with the SEC of J&J's Annual Report on Form 10-K covering such year
shall not be Incorporated Documents or be incorporated by reference herein or
be a part hereof from and after the filing of such Annual Report on Form 10-K.

     Any statement contained in an Incorporated Document or deemed to be
incorporated by reference herein shall be deemed to be modified or superseded
for purposes hereof to the extent that a statement contained herein or in any
other subsequently filed Incorporated Document modifies or supersedes such
statement. Any such statement so modified or superseded shall not be deemed,
except as so modified or superseded, to constitute a part hereof.

Item 4. Description of Securities.

     Not applicable.

Item 5. Interests of Named Experts and Counsel.

     The validity of the issuance of the J&J Common Stock being registered
hereby has been passed upon for J&J by Kenneth A. Berlin, Esq., General
Attorney, of J&J. Mr. Berlin is paid a salary by J&J, is a participant in
various employee benefit plans offered to employees of J&J generally and owns
and has options to purchase shares of J&J Common Stock.

Item 6. Indemnification of Directors and Officers.

     The New Jersey Business Corporation Act (the "NJBCA") provides that a New
Jersey corporation has the power to indemnify a director or officer against
his or her expenses and liabilities in connection with any proceeding
involving the director or officer by reason of his or her being or having been
such a director or officer, other than a proceeding by or in the right of the
corporation, if such director or officer acted in good faith and in a manner
he or she reasonably believed to be in or not opposed to the best interests of
the corporation; and with respect to any criminal proceeding, such director or
officer had no reasonable cause to believe his or her conduct was unlawful.

     The indemnification and advancement of expenses shall not exclude any
other rights, including the right to be indemnified against liabilities and
expenses incurred in proceedings by or in the right of the corporation, to
which a director or officer may be entitled under a certificate of
incorporation, by-law, agreement, vote of shareholders, or otherwise;
provided, that no indemnification shall be made to or on behalf of a director
or officer if a judgment or other final adjudication adverse to the director
or officer



<PAGE>


                                                                             3


establishes that his or her acts or omissions (a) were in breach of his or her
duty of loyalty to the corporation or its shareholders, (b) were not in good
faith or involved a knowing violation of law or (c) resulted in receipt by the
director or officer of an improper personal benefit.

     J&J's Restated Certificate of Incorporation provides that, to the full
extent that the laws of the State of New Jersey permit the limitation or
elimination of the liability of directors and officers, no director or officer
of J&J shall be personally liable to J&J or its stockholders for damages for
breach of any duty owed to J&J or its stockholders.

     The By-laws of J&J provide that, to the full extent permitted by the laws
of the State of New Jersey, J&J shall indemnify any person who was or is
involved in any manner (including, without limitation, as a party or witness)
in any threatened, pending or completed investigation, claim, action, suit or
proceeding, whether civil, criminal, administrative, arbitrative, legislative
or investigative (including, without limitation, any action, suit or
proceeding by or in the right of J&J to procure a judgment in its favor), or
who is threatened with being so involved, by reason of the fact that he or she
is or was a director or officer of J&J or, while serving as a director or
officer of J&J, is or was at the request of J&J also serving as a director,
officer, employee or agent of another corporation, partnership, joint venture,
trust or other enterprise (including, without limitation, any employee benefit
plan), against all expenses (including attorneys' fees), judgments, fines,
penalties, excise taxes and amounts paid in settlement actually and reasonably
incurred by the indemnitee in connection with such proceeding; provided that,
there shall be no indemnification under the By-Laws with respect to any
settlement or other nonadjudicated disposition of any threatened or pending
such proceeding unless J&J has given its prior consent to such settlement or
disposition. The right of indemnification created by the By-laws shall be a
contract right enforceable by an indemnitee against J&J, and it shall not be
exclusive of any other rights to which an indemnitee may otherwise be
entitled. The indemnification provisions of the By-laws shall inure to the
benefit of the heirs and legal representatives of an indemnitee and shall be
applicable to proceedings commenced or continuing after the adoption of the
By-laws, whether arising from acts or omissions occurring before or after such
adoption. No amendment, alteration, change, addition or repeal of or to the
By-laws shall deprive any indemnitee of any rights under the By-laws with
respect to any act or omission of such indemnitee occurring prior to such
amendment, alteration, change, addition or repeal.

     J&J enters into indemnification agreements with its directors and
officers and enters into insurance agreements on its own behalf. The
indemnification agreements provide that J&J agrees to hold harmless and
indemnify its directors and officers to the fullest extent authorized or
permitted by the NJBCA, or any other applicable law, or by any amendment
thereof or other statutory provisions authorizing or permitting such
indemnification that is adopted after the date hereof. Without limiting the
generality of the foregoing, J&J agrees to hold harmless and indemnify its
directors and officers to the fullest extent permitted by applicable law
against any and all expenses, judgments, fines, and amounts paid in settlement
actually and reasonably incurred by its directors and officers in connection
with the defense of any present or future threatened, pending, or completed
claim, action, suit, or proceeding by reason of the fact that they were, are,
shall be, or shall have been a director or officer of J&J, or are or were
serving, shall serve, or shall have served, at the request of J&J, as a
director or officer of another corporation, partnership, joint venture, trust,
employee benefit plan, or other enterprise.

Item 7. Exemption from Registration Claimed.

     Not applicable.

Item 8. Exhibits.

     See Exhibit Index.

Item 9. Undertakings.

(a)  J&J hereby undertakes:

(1) To file, during any period in which offers or sales are being made, a
post-effective amendment to this Registration Statement:

     (i) to include any prospectus required by Section 10(a)(3) of the
Securities Act of 1933 (the "Securities Act");

     (ii) to reflect in the prospectus any facts or events arising after the
effective date of the Registration Statement (or the most recent
post-effective amendment thereof) which, individually or in the aggregate,
represent a fundamental change in the information set forth in the
Registration Statement;


<PAGE>


                                                                             4


     (iii) to include any material information with respect to the plan of
distribution not previously disclosed in the Registration Statement or any
material change to such information in the Registration Statement;

provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if
the Registration Statement is on Form S-3 or Form S-8, and the information
required to be included in a post-effective amendment by those paragraphs is
contained in periodic reports filed by J&J pursuant to Section 13 or Section
15(d) of the Exchange Act that are incorporated by reference in this
Registration Statement.

(2) That, for the purpose of determining any liability under the Securities
Act, each such post-effective amendment shall be deemed to be a new
registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial
bona fide offering thereof.

(3) To remove from registration by means of a post-effective amendment any of
the securities being registered which remain unsold at the termination of the
offering.

(b) J&J hereby undertakes that, for purposes of determining any liability
under the Securities Act, each filing of J&J's annual report pursuant to
Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable,
each filing of an employee benefit plan's annual report pursuant to Section
15(d) of the Exchange Act) that is incorporated by reference in the
Registration Statement shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of such
securities at that time shall be deemed to be the initial bona fide offering
thereof.

(c) Insofar as indemnification for liabilities arising under the Securities
Act may be permitted to directors, officers and controlling persons of J&J
pursuant to the foregoing provisions, or otherwise, J&J has been advised that
in the opinion of the SEC such indemnification is against public policy as
expressed in the Securities Act and is, therefore, unenforceable. In the event
that a claim for indemnification against such liabilities (other than the
payment by J&J of expenses incurred or paid by a director, officer or
controlling person of J&J in the successful defense of any action, suit or
proceeding) is asserted by such director, officer or controlling person in
connection with the securities being registered, J&J will, unless in the
opinion of its counsel the matter has been settled by controlling precedent,
submit to a court of appropriate jurisdiction the question whether such
indemnification by it is against public policy as expressed in the Securities
Act and will be governed by the final adjudication of such issue.


<PAGE>

                                                                             5

                                  SIGNATURES

     Pursuant to the requirements of the Securities Act of 1933, the
registrant certifies that it has reasonable grounds to believe that it meets
all of the requirements for filing on Form S-8 and has duly caused this
Post-Effective Amendment to be signed on its behalf by the undersigned,
thereunto duly authorized, in the City of New Brunswick and State of New
Jersey on the 19th day of November, 1999.

                                       JOHNSON & JOHNSON


                                       By  /s/ R. S. Larsen
                                           ---------------------------
                                           Name: R. S. Larsen
                                           Title: Chairman and Chief
                                                  Executive Officer


     Pursuant to the requirements of the Securities Act of 1933, this
Post-Effective Amendment has been duly signed by the following persons in the
capacities and on the dates indicated.


Signature                Title                                Date


/s/ R. S. Larsen
- -----------------------  Chairman, Board of Directors,        November 19, 1999
(R. S. Larsen)           Chief Executive Officer and
                         Director
                         (Principal Executive Officer)


/s/ R. J. Darretta
- -----------------------  Vice President, Finance              November 19, 1999
 (R. J. Darretta)        (Principal Financial Officer)


/s/ C. E. Lockett
- -----------------------  Controller                           November 19, 1999
 (C. E. Lockett)         (Principal Accounting Officer)


/s/ G. N. Burrow
- -----------------------  Director                             November 19, 1999
 (G. N. Burrow)



- -----------------------  Director                             November   , 1999
 (J. G. Cooney)


/s/ J. G. Cullen
- -----------------------  Director                             November 19, 1999
(J. G. Cullen)


/s/ M. J. Folkman
- -----------------------  Director                             November 19, 1999
(M. J. Folkman)



<PAGE>

                                                                             6


Signature                Title                                Date


/s/ A. D. Jordan
- -----------------------  Director                             November 19, 1999
(A. D. Jordan)


/s/ A. G. Langbo
- -----------------------  Director                             November 19, 1999
(A. G. Langbo)


/s/ J. S. Mayo
- -----------------------  Director                             November 19, 1999
(J. S. Mayo)


/s/ L. F. Mullin
- -----------------------  Director                             November 19, 1999
(L. F. Mullin)


/s/ P. J. Rizzo
- -----------------------  Director                             November 19, 1999
(P. J. Rizzo)


/s/ H. B. Schacht
- -----------------------  Director                             November 19, 1999
(H. B. Schacht)


/s/ M. F. Singer
- -----------------------  Director                             November 19, 1999
(M. F. Singer)


/s/ J. W. Snow
- -----------------------  Director                             November 19, 1999
(J. W. Snow)


/s/ R. N. Wilson
- -----------------------  Director                             November 19, 1999
(R. N. Wilson)



<PAGE>



                                 EXHIBIT INDEX

Exhibit
Number                            Description

4.1       Provisions of the Restated Certificate of Incorporation of Johnson &
          Johnson dated May 21, 1996, that define the rights of
          securityholders of Johnson & Johnson (incorporated by reference to
          Exhibit 3 to Johnson & Johnson's Quarterly Report on Form 10-Q for
          the quarterly period ended June 30, 1996).

4.2       Provisions of the By-Laws of Johnson & Johnson, as amended effective
          April 23, 1999, that define the rights of securityholders of Johnson
          & Johnson (incorporated by reference to Exhibit 3 to Johnson &
          Johnson's Quarterly Report on Form 10-Q for the quarterly period
          ended July 4, 1999).

5.1       Opinion of Kenneth A. Berlin, Esq., General Attorney, of Johnson &
          Johnson, regarding the legality of the securities being issued.

23.1      Consent of PricewaterhouseCoopers LLP.

23.2      Consent of Kenneth A. Berlin, Esq., General Attorney, of Johnson &
          Johnson (included in Exhibit 5.1).


<PAGE>

                                                                   EXHIBIT 5.1



                       [Letterhead of Johnson & Johnson]




                                                             November 19, 1999



Johnson & Johnson
One Johnson & Johnson Plaza
New Brunswick, NJ 08933

Ladies and Gentlemen:

     I am a General Attorney of Johnson & Johnson, a New Jersey corporation
(the "Company"), and I am familiar with the Post-Effective Amendment No. 2 on
Form S-8 to the Registration Statement on Form S-4 (Registration No.
333-86611) (as so amended, the "Registration Statement") being filed by the
Company with the Securities and Exchange Commission under the Securities Act
of 1933, as amended, relating to 15,273 shares (the "Shares") of the Company's
Common Stock, par value $1.00 per share ("Common Stock"), issuable upon the
exercise of stock options granted under the Centocor, Inc. Consultant
Non-Qualified Stock Option Agreements, the Centocor, Inc. 1983 Incentive Stock
Option Plan, the Centocor, Inc. 1987 Non-Qualified Plan and the Centocor, Inc.
1989 Non-Employee Directors' Non-Qualified Stock Option Plan (collectively,
the "Plans"), which have been assumed by the Company in connection with the
merger of Admiral Merger Corp., a Pennsylvania corporation and a wholly owned
subsidiary of the Company ("Sub"), into Centocor, Inc., a Pennsylvania
corporation ("Centocor"), pursuant to the terms of the Agreement and Plan of
Merger dated as of July 20, 1999 (the "Merger Agreement"), among the Company,
Sub and Centocor.

     I have reviewed the Company's Restated Certificate of Incorporation and
By-laws and such other corporate records of the Company and documents and
certificates of public officials and others as I have deemed necessary as a
basis for the opinion hereinafter expressed.

     Based on the foregoing and having regard for such legal considerations as
I deem relevant, I am of the opinion that the Shares, when issued upon the
exercise of stock options under the Plans, will be duly authorized, validly
issued, fully paid and nonassessable.

     I hereby consent to the use of this opinion as an Exhibit to the
Registration Statement.


                                        Very truly yours,

                                        /s/ Kenneth A. Berlin
                                        ---------------------------
                                        Kenneth A. Berlin, Esq.
                                        General Attorney



<PAGE>


                                                                  EXHIBIT 23.1




                      CONSENT OF INDEPENDENT ACCOUNTANTS


We hereby consent to the incorporation by reference in this Post-Effective
Amendment No. 2 on Form S-8 to the Registration Statement on Form S-4 (No.
333-86611) of Johnson & Johnson of our report dated January 25, 1999 relating
to the consolidated financial statements, which appears in the Johnson &
Johnson 1998 Annual Report to Shareowners, which is incorporated by reference
in its Annual Report on Form 10-K for the fiscal year ended January 3, 1999.
We also consent to the incorporation by reference of our report dated January
25, 1999 relating to the financial statement schedule, which appears in such
Annual Report on Form 10-K.


                                        /s/ PricewaterhouseCoopers LLP
                                        ------------------------------------
                                        PricewaterhouseCoopers LLP


New York, New York
November 18, 1999



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission